Lichen planus-type drug eruption resulting from ticlopidine [2]

International Journal of Dermatology

Volumn 44, Issue 5, 2005, Pages 436-437

  Kurokawa, Ichiro ^a   Umehara, Makiko ^a   Nishijim, Setsuko ^b  

^a Hyogo Prefectural Tsukaguchi Hospital   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CILOSTAZOL; IBUDILAST; PENTOXIFYLLINE; TICLOPIDINE;

ABDOMINAL DISEASE; AGED; BRAIN INFARCTION; CASE REPORT; DRUG ERUPTION; DRUG WITHDRAWAL; ERYTHEMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; LICHEN PLANUS; LYMPHOCYTIC INFILTRATION; MALE; PAPULE; PATCH TEST; PROVOCATION TEST; PURPURA; SKIN BIOPSY; SKIN DEFECT;

EID: 18844457391     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2005.02266.x     Document Type: Letter

References (3)

1. Garcia CM, Carmena C, Garcia RC, et al. Fixed drug eruption from ticlopidine, with positive lesional patch test. Contact Dermatitis 2001; 44: 40-41.
2. His DH, Mock DJ, Rocco TA. Toxic erythroderma due to ticlopidine. N Engl J Med 1999; 340: 1212.
3. Yosipovitch G, Rechavia E, Feinmesser M, et al. Adverse cutaneous reactions to ticlopidine in patients with coronary stents. J Am Acad Dermatol 1999; 41: 473-476.